DERIVATIVES OF ACYLPHENYLUREA, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING
FIELD: organic chemistry, medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to new derivatives of acylphenylurea of the formula (I) and to their physiologically acceptable salts possessing property of glycogen phosphorylase inhibitors. In compound of the formula (I) A means phenyl an...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BURGER KHANS-JERG BARINGKHAUS KARL-KHAJNTS DEFOSSA EHLIZABET KHERLING ANDREAS KLABUNDE TOMAS |
description | FIELD: organic chemistry, medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to new derivatives of acylphenylurea of the formula (I) and to their physiologically acceptable salts possessing property of glycogen phosphorylase inhibitors. In compound of the formula (I) A means phenyl and phenyl residue can be substituted three times with fluorine (F), chlorine (Cl), bromine (Br) atoms, -CF3, -NO2, -O-(C1-C6)-alkyl, -SO2-(C1-C6)-alkyl, (C1-C6)-alkyl, -COOH; R1 means hydrogen atom (H), (C1-C6)-alkyl; R2 means H, (C1-C6(-alkyl, -CO-(C1-C6)-alkyl; 3, R4, R5 and R6 mean independently of one another H, F, Cl, Br, -O(C1-C6)-alkyl, (C1-C6)-alkyl, (C3-C7)-cycloalkyl, -COOH, -COO-(C1-C6)-alkyl; X means oxygen (O), sulfur (S) atom; R7 means (C1-C10)-alkylene-COOH, (C1-C10)-alkylene-COO-(C1-C6)-alkyl, (C1-C10)-alkylene-NH2, (C1-C10)-alkylene-NH-(C1-C6)-alkyl, (C1-C10)-alkylene-N-[(C1-C6)-alkyl]2, (C1-C10)-alkylene-B wherein B means piperidinyl or furyl. Also, invention relates to a pharmaceutical composition and a method for preparing the pharmaceutical composition. Proposed compounds can be used for preparing pharmaceutical composition useful for declining level of blood glucose and for treatment of diabetes mellitus type II. ^ EFFECT: improved preparing method, valuable medicinal properties of compounds and composition. ^ 7 cl, 2 sch, 2 tbl, 1 ex |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2271350C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2271350C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2271350C23</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-w31ABW0R5yO5mIM2Cdck0KkUiZNoof4_Ln6A01vetsqahDNGzjSAN4Bq7IIlN3ZJCGsIFqVHRSmywg6U74MfOLJ3gE5DT9F6DcYLcBwgCAUUdrd9tXnMz7Ucfu4qMBSVPZblPZV1me_lVT6TpKa5ntvLSTXtH-ULX04wrg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DERIVATIVES OF ACYLPHENYLUREA, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING</title><source>esp@cenet</source><creator>BURGER KHANS-JERG ; BARINGKHAUS KARL-KHAJNTS ; DEFOSSA EHLIZABET ; KHERLING ANDREAS ; KLABUNDE TOMAS</creator><creatorcontrib>BURGER KHANS-JERG ; BARINGKHAUS KARL-KHAJNTS ; DEFOSSA EHLIZABET ; KHERLING ANDREAS ; KLABUNDE TOMAS</creatorcontrib><description>FIELD: organic chemistry, medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to new derivatives of acylphenylurea of the formula (I) and to their physiologically acceptable salts possessing property of glycogen phosphorylase inhibitors. In compound of the formula (I) A means phenyl and phenyl residue can be substituted three times with fluorine (F), chlorine (Cl), bromine (Br) atoms, -CF3, -NO2, -O-(C1-C6)-alkyl, -SO2-(C1-C6)-alkyl, (C1-C6)-alkyl, -COOH; R1 means hydrogen atom (H), (C1-C6)-alkyl; R2 means H, (C1-C6(-alkyl, -CO-(C1-C6)-alkyl; 3, R4, R5 and R6 mean independently of one another H, F, Cl, Br, -O(C1-C6)-alkyl, (C1-C6)-alkyl, (C3-C7)-cycloalkyl, -COOH, -COO-(C1-C6)-alkyl; X means oxygen (O), sulfur (S) atom; R7 means (C1-C10)-alkylene-COOH, (C1-C10)-alkylene-COO-(C1-C6)-alkyl, (C1-C10)-alkylene-NH2, (C1-C10)-alkylene-NH-(C1-C6)-alkyl, (C1-C10)-alkylene-N-[(C1-C6)-alkyl]2, (C1-C10)-alkylene-B wherein B means piperidinyl or furyl. Also, invention relates to a pharmaceutical composition and a method for preparing the pharmaceutical composition. Proposed compounds can be used for preparing pharmaceutical composition useful for declining level of blood glucose and for treatment of diabetes mellitus type II. ^ EFFECT: improved preparing method, valuable medicinal properties of compounds and composition. ^ 7 cl, 2 sch, 2 tbl, 1 ex</description><language>eng ; rus</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060310&DB=EPODOC&CC=RU&NR=2271350C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060310&DB=EPODOC&CC=RU&NR=2271350C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BURGER KHANS-JERG</creatorcontrib><creatorcontrib>BARINGKHAUS KARL-KHAJNTS</creatorcontrib><creatorcontrib>DEFOSSA EHLIZABET</creatorcontrib><creatorcontrib>KHERLING ANDREAS</creatorcontrib><creatorcontrib>KLABUNDE TOMAS</creatorcontrib><title>DERIVATIVES OF ACYLPHENYLUREA, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING</title><description>FIELD: organic chemistry, medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to new derivatives of acylphenylurea of the formula (I) and to their physiologically acceptable salts possessing property of glycogen phosphorylase inhibitors. In compound of the formula (I) A means phenyl and phenyl residue can be substituted three times with fluorine (F), chlorine (Cl), bromine (Br) atoms, -CF3, -NO2, -O-(C1-C6)-alkyl, -SO2-(C1-C6)-alkyl, (C1-C6)-alkyl, -COOH; R1 means hydrogen atom (H), (C1-C6)-alkyl; R2 means H, (C1-C6(-alkyl, -CO-(C1-C6)-alkyl; 3, R4, R5 and R6 mean independently of one another H, F, Cl, Br, -O(C1-C6)-alkyl, (C1-C6)-alkyl, (C3-C7)-cycloalkyl, -COOH, -COO-(C1-C6)-alkyl; X means oxygen (O), sulfur (S) atom; R7 means (C1-C10)-alkylene-COOH, (C1-C10)-alkylene-COO-(C1-C6)-alkyl, (C1-C10)-alkylene-NH2, (C1-C10)-alkylene-NH-(C1-C6)-alkyl, (C1-C10)-alkylene-N-[(C1-C6)-alkyl]2, (C1-C10)-alkylene-B wherein B means piperidinyl or furyl. Also, invention relates to a pharmaceutical composition and a method for preparing the pharmaceutical composition. Proposed compounds can be used for preparing pharmaceutical composition useful for declining level of blood glucose and for treatment of diabetes mellitus type II. ^ EFFECT: improved preparing method, valuable medicinal properties of compounds and composition. ^ 7 cl, 2 sch, 2 tbl, 1 ex</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-w31ABW0R5yO5mIM2Cdck0KkUiZNoof4_Ln6A01vetsqahDNGzjSAN4Bq7IIlN3ZJCGsIFqVHRSmywg6U74MfOLJ3gE5DT9F6DcYLcBwgCAUUdrd9tXnMz7Ucfu4qMBSVPZblPZV1me_lVT6TpKa5ntvLSTXtH-ULX04wrg</recordid><startdate>20060310</startdate><enddate>20060310</enddate><creator>BURGER KHANS-JERG</creator><creator>BARINGKHAUS KARL-KHAJNTS</creator><creator>DEFOSSA EHLIZABET</creator><creator>KHERLING ANDREAS</creator><creator>KLABUNDE TOMAS</creator><scope>EVB</scope></search><sort><creationdate>20060310</creationdate><title>DERIVATIVES OF ACYLPHENYLUREA, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING</title><author>BURGER KHANS-JERG ; BARINGKHAUS KARL-KHAJNTS ; DEFOSSA EHLIZABET ; KHERLING ANDREAS ; KLABUNDE TOMAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2271350C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2006</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BURGER KHANS-JERG</creatorcontrib><creatorcontrib>BARINGKHAUS KARL-KHAJNTS</creatorcontrib><creatorcontrib>DEFOSSA EHLIZABET</creatorcontrib><creatorcontrib>KHERLING ANDREAS</creatorcontrib><creatorcontrib>KLABUNDE TOMAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BURGER KHANS-JERG</au><au>BARINGKHAUS KARL-KHAJNTS</au><au>DEFOSSA EHLIZABET</au><au>KHERLING ANDREAS</au><au>KLABUNDE TOMAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DERIVATIVES OF ACYLPHENYLUREA, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING</title><date>2006-03-10</date><risdate>2006</risdate><abstract>FIELD: organic chemistry, medicine, endocrinology, pharmacy. ^ SUBSTANCE: invention relates to new derivatives of acylphenylurea of the formula (I) and to their physiologically acceptable salts possessing property of glycogen phosphorylase inhibitors. In compound of the formula (I) A means phenyl and phenyl residue can be substituted three times with fluorine (F), chlorine (Cl), bromine (Br) atoms, -CF3, -NO2, -O-(C1-C6)-alkyl, -SO2-(C1-C6)-alkyl, (C1-C6)-alkyl, -COOH; R1 means hydrogen atom (H), (C1-C6)-alkyl; R2 means H, (C1-C6(-alkyl, -CO-(C1-C6)-alkyl; 3, R4, R5 and R6 mean independently of one another H, F, Cl, Br, -O(C1-C6)-alkyl, (C1-C6)-alkyl, (C3-C7)-cycloalkyl, -COOH, -COO-(C1-C6)-alkyl; X means oxygen (O), sulfur (S) atom; R7 means (C1-C10)-alkylene-COOH, (C1-C10)-alkylene-COO-(C1-C6)-alkyl, (C1-C10)-alkylene-NH2, (C1-C10)-alkylene-NH-(C1-C6)-alkyl, (C1-C10)-alkylene-N-[(C1-C6)-alkyl]2, (C1-C10)-alkylene-B wherein B means piperidinyl or furyl. Also, invention relates to a pharmaceutical composition and a method for preparing the pharmaceutical composition. Proposed compounds can be used for preparing pharmaceutical composition useful for declining level of blood glucose and for treatment of diabetes mellitus type II. ^ EFFECT: improved preparing method, valuable medicinal properties of compounds and composition. ^ 7 cl, 2 sch, 2 tbl, 1 ex</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; rus |
recordid | cdi_epo_espacenet_RU2271350C2 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | DERIVATIVES OF ACYLPHENYLUREA, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T15%3A23%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BURGER%20KHANS-JERG&rft.date=2006-03-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2271350C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |